The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Been a long term holder and follower of the science and similarly burnt last year but held through it all. Glad to see some familiar names on here and been scanning the BB since dreaded Feb 2022. Fingers crossed, hopefully some good news coming. GLA
Agree Sparky. I am still invested and taking best educated position that there will be a niche, perhaps quite a significant one, for this treatment. With stratified patients and perhaps, I hope, links to ameloirating effects of long COVID this could find a valuable place. But there is no crystal ball.... yes February was horrible.
Who knows, Polygon, Polar, maybe even S. R. Hadden?
For the record this is Scientific Reports, part of Nature Publishing Group (NPG), not Nature. But still a very high quality journal.
Good to see you back pmjh and very sorry to hear about your father.
Many thanks TLW for a well considered post.
Good spot xv, thank-you
Understand averaging and ramps perfectly clearly as a way out to whatever degree, just acknowledging it is a hell of a task.
Sometimes typos sum it all up Manifesto :)
'Until we get some further feedback we cannot really asses where we stand....'
The RNS today is intriguing (and as someone said delightful) but beyond me to fathom it beyond saying it strikes me as odd.
Since we are all amateurs with no business trading, perhaps ToffeeApple ToffAppleton or whatever their name was can offer their wisdom as to the tactics Polygon might employ to tack their way upstream with the price?
@Doc - Iike many on here I lost a considerable amount yesterday. If there were two sets of results forthcoming, one bad and one good, how would they play it? If Activ-2 was far better stratified in terms of patients maybe it will yield the positive news that justified progression and price goes back up, somewhat. You wouldn't RNS the other way round if it came to reporting within days.
I am personally simply awaiting a little more info. and wondering what do with portfolio and cash position before Putin sees to trashing the rest of it.
As for the trial and steroids, don't see how they could do it any other way. It would be like taking away the oxygen just to see if SNG-001 had any effect in its absence.
I got a live price of 10p from HL
Good post Jim - a reminder this is far from over in some form or another and why we are all still watching this company. I can hand on heart say that I have never in my whole career waited for an experimental result like this. Sure we are invested but the scientific question, the evidence that it should and then seeing if this actually works is tantalising to put it mildly.
On LinkedIn as well - advertising recruitment
Buzz..... still makes me smile.
Hi Doc - have you recovered okay?
Cheers buddy, thanks for replying. SC
Hi Ducati2- Thanks for the post. Do you mind sharing where that was post from Dr Nikolic appeared? Cheers, SC
Fizzy - I would hope not - this needs to be squeaky clean and the last thing you would want is leaks, legal battles or goodness knows what. I don't know what I am talking about but I do believe that big players would do anything to undermine the big win of a smaller player.
Agree Stottie - pure logistics and any reduction in hospital time will be a major advantage. If that benefit is demonstrated it will be huge and Q1 2022 is going to be the time.
I hoped Jeremy Farrar's statement about being closer to the start of the pandemic than the end isn't true, but I wouldn't bet my house on it.
Gosh, just realised I missed the buffoon. Will catch up now.